— Know what they know.
Not Investment Advice
Also trades as: ABDXF (OTC) · $vol 0M

ABDX.L LSE

Abingdon Health Plc
1W: +0.7% 1M: -1.7% 3M: +3.1% YTD: +76.2% 1Y: +92.2% 3Y: +0.7% 5Y: -83.0%
£10.57 ($0.14)
-0.43 (-3.95%)
 
Weekly Expected Move ±3.8%
£10 £10 £11 £11 £11
LSE · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 65 · £27.8M mcap · 241M float · 0.136% daily turnover

Balance Sheet Trends

Total Assets
$9M +83.0% ▲
5Y CAGR: -3.2%
Total Liabilities
$4M +41.3% ▲
5Y CAGR: -13.4%
Shareholders Equity
$5M +135.7% ▲
5Y CAGR: +14.0%
Cash & Investments
$2M +33.2% ▲
5Y CAGR: -15.3%
Total Debt
$1M -2.0% ▼
5Y CAGR: -26.4%
Net Debt
-$890K -127.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$5M$2M$3M$1M$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$5M$2M$3M$1M$2M
Net Receivables$10M$8M$1M$1M$3M
Inventory$8M$534K$329K$441K$526K
Other Current Assets$0-$311K$99K$584K$0
Total Current Assets$23M$11M$5M$4M$5M
Property, Plant & Equip.$9M$2M$1M$997K$1M
Goodwill & Intangibles$2M$36K$90K$532K$3M
Long-Term Investments$0$0$0$13K$354K
Other Non-Current Assets-$763K$0$0$0$0
Total Non-Current Assets$10M$2M$1M$2M$4M
Total Assets$33M$13M$6M$5M$9M
— Liabilities —
Accounts Payable$4M$2M$1M$605K$765K
Short-Term Debt$125K$115K$87K$0$93K
Deferred Revenue$5M$440K$50K$0$0
Other Current Liabilities$199K$2M$98K$1M$1M
Total Current Liabilities$11M$5M$2M$2M$3M
Long-Term Debt$367K$435K$708K$722K$652K
Other Non-Current Liab.$0$0$85K$88K$327K
Total Non-Current Liabilities$1M$1M$1M$1M$1M
Total Liabilities$12M$6M$3M$3M$4M
— Equity —
Common Stock$69K$76K$76K$32K$94K
Retained Earnings-$3M-$24M-$27M-$29M-$32M
Accumulated OCI$44K$153K$80K$169K$336K
Total Stockholders Equity$21M$6M$3M$2M$5M
Total Liabilities & Equity$33M$13M$6M$5M$9M
— Key Metrics —
Total Debt$1M$1M$1M$1M$1M
Net Debt-$3M-$1M-$2M-$391K-$890K
Total Investments$0$0$0$13K$354K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms